Geneviève Tanguay
Présidente-directrice générale (PDG) / Chief Executive Officer (CEO) @ Anges Quebec
Montréal, Canada
Geneviève Tanguay is a seed investor at Anges Quebec in Montréal focused on Health Care and Medical Device. Geneviève Tanguay is the Partner of Panache Ventures. Geneviève Tanguay is the Présidente-directrice générale (PDG) / Chief Executive Officer (CEO) of Anges Québec. She received her Bachelor's Degree, Business and Finance from HEC Montréal.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Geneviève Tanguay invests in
Stages Geneviève Tanguay invests in
Countries Geneviève Tanguay invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Medical Device 1 (50%)
- Health Diagnostics 1 (50%)
- Artificial Intelligence 1 (50%)
Stage
- Seed 1 (50%)
- Pre-Seed 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD.Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity. | $3.2M / Seed / Aug 11, 2021 | ||
| Gray Oncology Solutions has a vision of an oncology workflow where each patient’s journey through their cancer treatment is personalized for them, and statistically optimized to provide the best possible clinical outcomes. In pursuit of this vision, we’re developing resource allocation software focused on optimizing the functional efficiency ofentire cancer centers resulting in reduced patient wait-times, higher patient throughput, reduced stress and ultimately, superior patient care. | $999.9K / Pre-Seed / Aug 05, 2021 |
Co-Investors
About Anges Quebec
Founded in 2008, Anges Québec is a network of more than 230 angel investors whose mission is to invest capital and time in innovative Québec-based companies from all sectors of activity. The members of the Anges Québec network have, to date, invested more than $ 80 million in the Québec economy, with more than 210 investments in more than 115innovative companies. Thanks to its professional development center, Anges Québec supports its members in the constant acquisition of new knowledge and skills inherent in the investment.
Anges Quebec Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Genevieve Morin
President and CEO
|
|||
|
Patrick Pierra
Member
|
|||
André Forest
External collaborator and investing member
|
|||
Enzo Blasi
Member
|
|||
Jean-Francois Boyer
Angel investor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Geneviève Tanguay invest in?
Geneviève Tanguay invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Geneviève Tanguay?
Public channels for Geneviève Tanguay include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Geneviève Tanguay last invest?
The most recent investment recorded for Geneviève Tanguay closed in Aug 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
